Correction to “Efficacy of Lactobacillus spp. Supplementation in Helicobacter pylori Eradication: A Systematic Meta-Analysis of Randomized Controlled Trials With Trial Sequential Analysis”

IF 4.3 2区医学 Q1 GASTROENTEROLOGY & HEPATOLOGY

Helicobacter Pub Date : 2025-05-15 DOI:10.1111/hel.70044

引用次数: 0

Abstract

V. Mishra, D. Dash, A. K. Panda, et al., “Efficacy of Lactobacillus spp. Supplementation in Helicobacter pylori Eradication: A Systematic Meta-Analysis of Randomized Controlled Trials With Trial Sequential Analysis,” Helicobacter 29, no. 6 (2024): e70006, doi: https://doi.org/10.1111/hel.70006.

In the Abstract, Results (Sections 3.3–3.4), and GRADE evidence profile (Table 1), the risk ratio (RR) 95% CI values were mistakenly reported from Egger's regression 95% CI values (Table S3). Below, we provide a table of actual 95% CI values for RR as reported in the Forest plots (Figures 1–4).

We apologize for this error.

查看原文本刊更多论文

更正“补充乳酸杆菌根除幽门螺杆菌的功效：随机对照试验的系统荟萃分析与试验序列分析”

V. Mishra， D. Dash， A. K. Panda等，“补充乳酸杆菌对根除幽门螺杆菌的功效：随机对照试验的系统荟萃分析与试验序列分析”，《幽门螺杆菌》，第29期。6 (2024): e70006, doi: https://doi.org/10.1111/hel.70006.In摘要，结果（3.3-3.4节）和GRADE证据概要（表1），风险比（RR） 95% CI值错误地报告了Egger's回归95% CI值（表S3）。下面，我们提供了Forest图中报告的RR的实际95% CI值的表格（图1-4）。我们为这个错误道歉。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Helicobacter 医学-微生物学

CiteScore

8.40

自引率

9.10%

发文量

审稿时长

2 months

期刊介绍： Helicobacter is edited by Professor David Y Graham. The editorial and peer review process is an independent process. Whenever there is a conflict of interest, the editor and editorial board will declare their interests and affiliations. Helicobacter recognises the critical role that has been established for Helicobacter pylori in peptic ulcer, gastric adenocarcinoma, and primary gastric lymphoma. As new helicobacter species are now regularly being discovered, Helicobacter covers the entire range of helicobacter research, increasing communication among the fields of gastroenterology; microbiology; vaccine development; laboratory animal science.